HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Aung Naing Selected Research

temsirolimus

7/2015The Prevalence and Impact of Hyperglycemia and Hyperlipidemia in Patients With Advanced Cancer Receiving Combination Treatment With the Mammalian Target of Rapamycin Inhibitor Temsirolimus and Insulin Growth Factor-Receptor Antibody Cixutumumab.
4/2014Advanced gynecologic malignancies treated with a combination of the VEGF inhibitor bevacizumab and the mTOR inhibitor temsirolimus.
4/2014Incidence of mucositis in patients treated with temsirolimus-based regimens and correlation to treatment response.
12/2013Phase I clinical trial of lenalidomide in combination with temsirolimus in patients with advanced cancer.
12/2013A pilot study of temsirolimus and body composition.
10/2012Phase I study of the antiangiogenic antibody bevacizumab and the mTOR/hypoxia-inducible factor inhibitor temsirolimus combined with liposomal doxorubicin: tolerance and biological activity.
5/2012Insulin growth factor-receptor (IGF-1R) antibody cixutumumab combined with the mTOR inhibitor temsirolimus in patients with refractory Ewing's sarcoma family tumors.
9/2011Phase I trial of cixutumumab combined with temsirolimus in patients with advanced cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Aung Naing Research Topics

Disease

62Neoplasms (Cancer)
09/2015 - 03/2009
11Neoplasm Metastasis (Metastasis)
08/2015 - 03/2009
8Thrombocytopenia (Thrombopenia)
06/2015 - 11/2010
7Neutropenia
08/2015 - 11/2010
7Fatigue
08/2015 - 01/2011
5Ovarian Neoplasms (Ovarian Cancer)
06/2014 - 03/2012
5Colorectal Neoplasms (Colorectal Cancer)
03/2014 - 01/2012
4Exanthema (Rash)
08/2015 - 11/2009
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2015 - 10/2010
4Mucositis
04/2014 - 07/2011
3Melanoma (Melanoma, Malignant)
11/2015 - 11/2009
3Breast Neoplasms (Breast Cancer)
12/2014 - 10/2013
3Anoxia (Hypoxia)
11/2014 - 11/2011
2Weight Loss (Weight Reduction)
09/2015 - 12/2013
2Body Weight (Weight, Body)
09/2015 - 12/2013
2Diarrhea
08/2015 - 06/2012
2Hypercholesterolemia
07/2015 - 04/2014
2Sarcoma (Soft Tissue Sarcoma)
01/2015 - 12/2013
2Thyroid Neoplasms (Thyroid Cancer)
01/2015 - 04/2011
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2015 - 10/2013
2Circulating Neoplastic Cells
07/2014 - 08/2013
2Hypertension (High Blood Pressure)
07/2014 - 04/2014
2Endometrial Neoplasms (Endometrial Cancer)
05/2014 - 03/2012
2Adenoid Cystic Carcinoma (Cylindroma)
04/2014 - 12/2013
2Prostatic Neoplasms (Prostate Cancer)
03/2014 - 10/2010
2Carcinoma (Carcinomatosis)
12/2013 - 06/2012
2Dehydration (Water Stress)
08/2013 - 06/2012
2Pancreatic Neoplasms (Pancreatic Cancer)
08/2013 - 11/2009
2Ewing's Sarcoma (Sarcoma, Ewing)
05/2012 - 01/2011
1Fibrosis (Cirrhosis)
09/2015
1Cachexia
09/2015
1Vomiting
09/2015
1Weight Gain
09/2015
1Nausea
09/2015
1Pancreatitis
09/2015
1Hypertriglyceridemia
07/2015
1Hyperglycemia
07/2015
1Hyperlipidemias (Hyperlipidemia)
07/2015
1Alopecia (Baldness)
01/2015
1Papilloma (Papillomatosis)
01/2015

Drug/Important Bio-Agent (IBA)

16bevacizumabFDA Link
08/2015 - 11/2011
9Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2015 - 01/2013
8temsirolimusFDA Link
07/2015 - 09/2011
6tranilast (N 5')IBA
01/2015 - 03/2012
5DNA (Deoxyribonucleic Acid)IBA
09/2015 - 01/2011
5oxaliplatin (Eloxatin)FDA LinkGeneric
08/2015 - 06/2012
4cetuximab (Erbitux)FDA Link
08/2015 - 02/2013
4Insulin (Novolin)FDA Link
07/2015 - 01/2011
4sorafenib (BAY 43-9006)FDA Link
02/2015 - 11/2009
4PlatinumIBA
01/2015 - 06/2012
4Phosphotransferases (Kinase)IBA
04/2014 - 04/2011
3AntigensIBA
09/2015 - 03/2009
3lenalidomide (CC 5013)FDA Link
04/2015 - 12/2013
3Lipase (Acid Lipase)FDA Link
01/2015 - 01/2011
3Carboplatin (JM8)FDA LinkGeneric
06/2014 - 06/2012
3Aspartate Aminotransferases (Aspartate Transaminase)IBA
04/2014 - 03/2009
3erlotinib (CP 358,774)FDA Link
01/2014 - 01/2013
3Doxorubicin (Adriamycin)FDA LinkGeneric
10/2012 - 11/2010
2irinotecan (Camptosar)FDA LinkGeneric
08/2015 - 10/2013
2Sirolimus (Rapamycin)FDA Link
07/2015 - 01/2011
2everolimusFDA Link
06/2015 - 05/2014
2Valproic Acid (Valproate, Semisodium)FDA LinkGeneric
04/2015 - 03/2014
2anaplastic Thyroid cancerIBA
01/2015 - 06/2012
2AmylasesFDA Link
01/2015 - 04/2011
2Trientine (Trien)FDA Link
06/2014 - 06/2012
2Cisplatin (Platino)FDA LinkGeneric
10/2013 - 11/2010
2gemcitabineFDA Link
08/2013 - 04/2013
2130-nm albumin-bound paclitaxelIBA
04/2013 - 07/2011
2Fluorouracil (Carac)FDA LinkGeneric
02/2013 - 01/2013
2Messenger RNA (mRNA)IBA
06/2012 - 10/2011
2Paclitaxel (Taxol)FDA LinkGeneric
06/2012 - 07/2011
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
05/2012 - 03/2009
2medullary Thyroid cancerIBA
04/2011 - 11/2009
1Biological Markers (Surrogate Marker)IBA
11/2015
1Angiopoietin-1IBA
11/2015
1Formaldehyde (Formol)FDA Link
09/2015
1ParaffinIBA
09/2015
1SodiumIBA
09/2015
1Interleukin-6 (Interleukin 6)IBA
09/2015
1CytokinesIBA
09/2015
1PeptidesIBA
09/2015
1olanzapine (Zyprexa)FDA Link
09/2015
1GhrelinIBA
09/2015
1LeptinIBA
09/2015
1Growth Hormone (Somatotropin)IBA
09/2015
1Thrombocytopenia chromosome breakageIBA
08/2015
1Glucose (Dextrose)FDA LinkGeneric
07/2015
1thymidine 5'-triphosphate (TTP)IBA
07/2015
1pazopanibIBA
06/2015
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
06/2015
1Interleukin-1alpha (Interleukin 1 alpha)IBA
06/2015
1CreatinineIBA
06/2015
1trastuzumab (Herceptin)FDA Link
02/2015
1lapatinib (GW572016)FDA Link
02/2015
1Azacitidine (5 Azacytidine)FDA Link
01/2015
1Tryptophan (L-Tryptophan)FDA Link
01/2015
1IodineIBA
01/2015
1Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
01/2015

Therapy/Procedure

7Drug Therapy (Chemotherapy)
05/2014 - 11/2010
2Individualized Medicine
09/2014 - 11/2012